Abstract
Isocitrate dehydrogenase (IDH) inhibitors comprise a novel class of anticancer drugs, which are approved to treat acute myeloid leukemia patients havi......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
